Compare PSEC & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSEC | AORT |
|---|---|---|
| Founded | 2004 | 1984 |
| Country | United States | United States |
| Employees | 8 | N/A |
| Industry | Finance/Investors Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | N/A | 1996 |
| Metric | PSEC | AORT |
|---|---|---|
| Price | $2.25 | $20.36 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $2.50 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 5.8M | 732.2K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | ★ 20.07% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | N/A | $11.20 |
| P/E Ratio | ★ N/A | $679.67 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $2.11 | $19.16 |
| 52 Week High | $3.50 | $48.25 |
| Indicator | PSEC | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 39.93 | 25.08 |
| Support Level | $2.11 | $19.16 |
| Resistance Level | $2.95 | $24.70 |
| Average True Range (ATR) | 0.08 | 1.06 |
| MACD | 0.01 | 0.20 |
| Stochastic Oscillator | 37.04 | 9.43 |
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.